Health systems’ financial results so far this year suggest the start of a gradual and sustained recovery, though there are persistent challenges — such as high costs for drugs and supplies, as well as…
Continue Reading
Musculoskeletal company Hinge Health and menopause company Midi Health launched a partnership Tuesday to support women going through menopause.
San Francisco-based Hinge Health serves payers and employers and provides physical therapy for the neck, upper…
Continue Reading
#johnlynn #3Pillar #healthcareai #HealthcareChatbots #HealthcareITVideoInterviews #healthcarescenefeatured #PayerChatbots #PayerIT #PayerITModernization #Payers #RCM #RevenueCycleManagement #steverowe…
Continue Reading
Waltz Health, a digital health company focused on prescription drugs, launched Waltz Connect on Monday. The new solution aims to reduce the cost of specialty medications.
Chicago-based Waltz Health was founded in 2021 and serves…
Continue Reading
What You Should Know:
– Waltz Health, a digital health company developing smarter, technology-enabled ways to price, distribute and prescribe medications, today unveiled Waltz Connect, a new end-to-end solution that manages all aspects of a payer’s…
Continue Reading
The following is a guest article by Shikha Bajaj, VP, Healthcare Transformation & Medtech Lead at Publicis Sapient
For many, finding an in-network doctor or booking an appointment feels like navigating a maze. There’s no…
#ColinBanas #drfirst #GoldCarding #healthcareitvideointerviews #HealthcareSceneFeatured #MyndShyft #PriorAuth #PriorAuthAutomation #PriorAuthorizations #unitedhealthcare #johnlynn…
Continue Reading
#johnlynn #3Pillar #healthcareai #HealthcareChatbots #HealthcareITVideoInterviews #healthcarescenefeatured #PayerChatbots #PayerIT #PayerITModernization #Payers #RCM #RevenueCycleManagement #steverowe…
Continue Reading
Digital therapeutics have significantly improved access to care for many patients, while delivering consistent clinical outcomes across a wide range of conditions. However, despite the potential these new treatments offer, convincing payers to embrace…
Continue Reading
When the FDA approves a drug, passing that regulatory bar of safety and efficacy puts it on the path toward likely reimbursement by government and commercial payers. The same has not been true for…
Continue Reading
